Últimas noticias sobre WR Berkley (NYSE:WRB) Bolsa

WR BERKLEY CORP

WR Berkley

W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.

WR Berkley Corp

Warby Parker Inc

W.R. Berkley Corporation 5.70% Subordinated Debentures due 2058

W.R. Berkley Corporation 5.10% Subordinated Debentures due 2059

W.R. Berkley Corporation 4.25% Subordinated Debentures due 2060

W.R. Berkley Corporation 4.125% Subordinated Debentures due 2061

WR Berkley's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) short percent of float has fallen 28.5% since its last report. The company recently reported that it has 4.28 million shares sold short, which is 1.43% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.69 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>WR Berkley Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745946029_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for WR Berkley has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing WR Berkley's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, WR Berkley's peer group average for short interest as a percentage of float is 2.39%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

How Is The Market Feeling About WR Berkley?

UBS analyst Brian Meredith maintains WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) with a Buy and raises the price target from $73 to $78.

News

Price Target

Analyst Ratings

UBS Maintains Buy on WR Berkley, Raises Price Target to $78

Ratings for WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) were provided by 12 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">8</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $66.17, a high estimate of $80.00, and a low estimate of $52.00. Observing a 5.17% increase, the current average has risen from the previous average price target of $62.92. 
<img src="https://www.benzinga.com/files/images/story/2025/1745330497_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of WR Berkley among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Meyer Shields &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Market Perform &#x7C; $65.00&#x7C;$62.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $70.00&#x7C;$69.00 &#x7C; 
&#x7C;Alex Scott &#x7C;Barclays &#x7C;Raises &#x7C;Underweight &#x7C; $62.00&#x7C;$52.00 &#x7C; 
&#x7C;Yaron Kinar &#x7C;Jefferies &#x7C;Raises &#x7C;Hold &#x7C; $66.00&#x7C;$57.00 &#x7C; 
&#x7C;Meyer Shields &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Market Perform &#x7C; $62.00&#x7C;$64.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $69.00&#x7C;$70.00 &#x7C; 
&#x7C;Mark Hughes &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $80.00&#x7C;$68.00 &#x7C; 
&#x7C;Joshua Shanker &#x7C;B of A Securities &#x7C;Raises &#x7C;Neutral &#x7C; $74.00&#x7C;$73.00 &#x7C; 
&#x7C;Scott Heleniak &#x7C;RBC Capital &#x7C;Maintains &#x7C;Sector Perform &#x7C; $63.00&#x7C;$63.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Raises &#x7C;Overweight &#x7C; $70.00&#x7C;$67.00 &#x7C; 
&#x7C;Meyer Shields &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Market Perform &#x7C; $61.00&#x7C;$60.00 &#x7C; 
&#x7C;Alex Scott &#x7C;Barclays &#x7C;Raises &#x7C;Underweight &#x7C; $52.00&#x7C;$50.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to WR Berkley. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of WR Berkley compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for WR Berkley's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of WR Berkley's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/WRB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on WR Berkley analyst ratings.</a>
<h2>Discovering WR Berkley: A Closer Look</h2>
W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.
<h3>Financial Milestones: WR Berkley's Journey</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Positive Revenue Trend: Examining WR Berkley's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 16.73% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: WR Berkley's net margin excels beyond industry benchmarks, reaching 15.48%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): WR Berkley's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 6.85% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): WR Berkley's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.42% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.34, caution is advised due to increased financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On WR Berkley Through 12 Analysts

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) with a Market Perform and raises the price target from $62 to $65.

Keefe, Bruyette & Woods Maintains Market Perform on WR Berkley, Raises Price Target to $65

Wells Fargo analyst Elyse Greenspan maintains WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) with a Equal-Weight and raises the price target from $69 to $70.

Wells Fargo Maintains Equal-Weight on WR Berkley, Raises Price Target to $70

WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) reported quarterly earnings of $1.01 per share which beat the analyst consensus estimate of $0.98 by 3.06 percent. This is a 2.88 percent decrease over earnings of $1.04 per share from the same period last year. The company reported quarterly sales of $3.55 billion which beat the analyst consensus estimate of $3.53 billion by 0.47 percent. This is a 8.92 percent increase over sales of $3.26 billion the same period last year.

Earnings

Earnings Beats

WR Berkley Q1 Adj $1.01 Beats $0.98 Estimate, Sales $3.55B Beat $3.53B Estimate

W. R. Berkley Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) will release earnings results for the first quarter, after the <a href="https://www.benzinga.com/quote/wrb/earnings">closing bell on Monday, April 21.</a>
Analysts expect the Greenwich, Connecticut-based company to report quarterly earnings at 99 cents per share, down from $1.04 per share in the year-ago period. W. R. Berkley projects to report quarterly revenue at $3.02 billion, compared to $2.76 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On March 28, W. R. Berkley confirmed that Japan&#8217;s Mitsui Sumitomo Insurance (MSI) will acquire a 15% stake through a newly announced investment and voting agreement.
W. R. Berkley shares rose 0.5% to close at $68.80 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/wrb/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Jefferies analyst Yaron Kinar maintained a Hold rating and raised the price target from $57 to $66 on April 11, 2025. This analyst has an accuracy rate of 75%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Meyer Shields maintained a Market Perform rating and slashed the price target from $64 to $62 on April 9, 2025. This analyst has an accuracy rate of 80%.</li>
<li>Wells Fargo analyst Elyse Greenspan downgraded the stock from Overweight to Equal-Weight and cut the price target from $70 to $69 on April 9, 2025. This analyst has an accuracy rate of 75%.</li>
<li>Truist Securities analyst Mark Hughes maintained a Buy rating and increased the price target from $68 to $80 on April 3, 2025. This analyst has an accuracy rate of 84%.</li>
<li>B of A Securities analyst Joshua Shanker downgraded the stock from Buy to Neutral and increased the price target from $73 to $74 on April 1, 2025. This analyst has an accuracy rate of 75%.</li>
</ul>
Considering buying WRB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="609" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21015632/image-28-1024x609.png" alt="" class="wp-image-878922" style="width:520px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21015632/image-28-1024x609.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21015632/image-28-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21015632/image-28-768x456.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21015632/image-28.png 1077w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:<a href="https://www.benzinga.com/25/04/44862261/top-3-materials-stocks-that-are-ticking-portfolio-bombs"> </a>
<ul>
<li><a href="https://www.benzinga.com/25/04/44862261/top-3-materials-stocks-that-are-ticking-portfolio-bombs">Top 3 Materials Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Top Wall Street Forecasters Revamp W. R. Berkley Expectations Ahead Of Q1 Earnings

<h3>Companies Reporting Before The Bell</h3>
• MainStreet Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNSB#NASDAQ">MNSB</a>) is estimated to report quarterly earnings at $0.21 per share on revenue of $17.21 million. 
• HBT Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBT#NASDAQ">HBT</a>) is likely to report quarterly earnings at $0.56 per share on revenue of $57.31 million. 
• Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) is likely to report quarterly earnings at $1.13 per share on revenue of $831.34 million. 
• Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) is expected to report earnings for its fourth quarter. 
• Dynex Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DX#NYSE">DX</a>) is expected to report quarterly earnings at $0.37 per share on revenue of $11.41 million. 
• Washington Trust Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WASH#NASDAQ">WASH</a>) is estimated to report quarterly earnings at $0.63 per share on revenue of $53.16 million. 
• Bank of Hawaii (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOH#NYSE">BOH</a>) is projected to report quarterly earnings at $0.89 per share on revenue of $169.27 million. 
• Guaranty Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNTY#NYSE">GNTY</a>) is estimated to report quarterly earnings at $0.71 per share on revenue of $31.10 million. 
• Capital City Bank Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCBG#NASDAQ">CCBG</a>) is expected to report quarterly earnings at $0.74 per share on revenue of $59.75 million. 
• Addex Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) is estimated to report earnings for its fourth quarter. 
<h3>Companies Reporting After The Bell</h3>
• Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) is expected to report quarterly earnings at $1.78 per share on revenue of $791.97 million. 
• Equity Lifestyle Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELS#NYSE">ELS</a>) is likely to report quarterly earnings at $0.83 per share on revenue of $399.02 million. 
• SmartFinancial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMBK#NYSE">SMBK</a>) is likely to report quarterly earnings at $0.55 per share on revenue of $46.23 million. 
• Servisfirst Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SFBS#NYSE">SFBS</a>) is estimated to report quarterly earnings at $1.18 per share on revenue of $134.10 million. 
• Home Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBCP#NASDAQ">HBCP</a>) is likely to report quarterly earnings at $1.14 per share on revenue of $30.90 million. 
• Trustco Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRST#NASDAQ">TRST</a>) is projected to report earnings for its first quarter. 
• AZZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) is estimated to report quarterly earnings at $0.98 per share on revenue of $367.78 million. 
• Metropolitan Bank Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCB#NYSE">MCB</a>) is estimated to report quarterly earnings at $1.56 per share on revenue of $68.40 million. 
• Hexcel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HXL#NYSE">HXL</a>) is projected to report quarterly earnings at $0.43 per share on revenue of $478.67 million. 
• Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) is estimated to report quarterly earnings at $1.18 per share on revenue of $795.15 million. 
• AGNC Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGNC#NASDAQ">AGNC</a>) is expected to report quarterly earnings at $0.40 per share on revenue of $436.71 million. 
• WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) is projected to report quarterly earnings at $1.04 per share on revenue of $3.02 billion. 
• Cathay General (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CATY#NASDAQ">CATY</a>) is expected to report quarterly earnings at $0.95 per share on revenue of $186.16 million. 
• Wintrust Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTFC#NASDAQ">WTFC</a>) is likely to report quarterly earnings at $2.49 per share on revenue of $643.83 million. 
• Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) is projected to report quarterly earnings at $0.13 per share on revenue of $206.98 million. 
• Cadence Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CADE#NYSE">CADE</a>) is expected to report quarterly earnings at $0.64 per share on revenue of $451.05 million. 
• Flexsteel Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLXS#NASDAQ">FLXS</a>) is likely to report quarterly earnings at $0.81 per share on revenue of $109.47 million. 
• BOK Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOKF#NASDAQ">BOKF</a>) is likely to report quarterly earnings at $1.99 per share on revenue of $520.72 million. 
• Medpace Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) is estimated to report quarterly earnings at $3.09 per share on revenue of $540.55 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADXN

AGNC

BOKF

CADE

CALX

CATY

CCBG

FLXS

GNTY

HBCP

MEDP

MNSB

SFBS

SMBK

TRST

WASH

WTFC

ZION

Earnings Scheduled For April 21, 2025

WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) will release its quarterly earnings report on Monday, 2025-04-21. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate WR Berkley to report an earnings per share (EPS) of $1.04.
WR Berkley bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.18, leading to a 0.24% increase in the share price on the subsequent day.
Here's a look at WR Berkley's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.95</td>
<td>0.92</td>
<td>0.92</td>
<td>0.96</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.13</td>
<td>0.93</td>
<td>1.04</td>
<td>1.04</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>-4.0%</td>
<td>1.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744988443_0.png" alt="eps graph" />
<h3>Tracking WR Berkley's Stock Performance</h3>
Shares of WR Berkley were trading at $68.45 as of April 16. Over the last 52-week period, shares are up 23.7%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/WRB/earnings">To track all earnings releases for WR Berkley visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: WR Berkley's Earnings

Barclays analyst Alex Scott maintains WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) with a Underweight and raises the price target from $52 to $62.

Barclays Maintains Underweight on WR Berkley, Raises Price Target to $62

Jefferies analyst Yaron Kinar maintains WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) with a Hold and raises the price target from $57 to $66.

Jefferies Maintains Hold on WR Berkley, Raises Price Target to $66

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) with a Market Perform and lowers the price target from $64 to $62.

Keefe, Bruyette & Woods Maintains Market Perform on WR Berkley, Lowers Price Target to $62

Wells Fargo analyst Elyse Greenspan downgrades WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) from Overweight to Equal-Weight and lowers the price target from $70 to $69.

Downgrades

Wells Fargo Downgrades WR Berkley to Equal-Weight, Lowers Price Target to $69

U.S. stocks settled lower on Friday, with the Dow Jones index tumbling over 2,200 points during the session.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst&#8217;s opinion to trust.
Benzinga&#8217;s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. One of the ways traders can sort through Benzinga&#8217;s extensive database of analyst ratings is by analyst accuracy. Here&#8217;s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock</a> Ratings.
Analyst: Mark Hughes
<ul>
<li>Analyst Firm: Truist Securities</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Maintained a Buy rating on W. R. Berkley Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) and increased the price target from $68 to $80 on April 3. This analyst sees around 25% upside in the stock.</li>
<li>Recent News: On April 1, W. R. Berkley named Michael G. MacMullin President of Berkley Luxury Group.</li>
</ul>
Analyst: Matthew Carletti
<ul>
<li>Analyst Firm: Citizens Capital Markets</li>
<li>Ratings Accuracy: 84%</li>
<li>Latest Rating: Downgraded rating on ProAssurance Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) from Market Outperform to Market Perform on April 3.</li>
<li>Recent News: On March 19, ProAssurance announced it will be acquired by The Doctors Company for $25.00 per share in cash.</li>
</ul>
Analyst: Zachary Fadem 
<ul>
<li>Analyst Firm: Wells Fargo</li>
<li>Ratings Accuracy: 84%</li>
<li>Latest Rating: Maintained an Overweight rating on RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) and slashed the price target from $375 to $300 on April 3. This analyst sees around 76% upside in the stock.</li>
<li>Recent News: On April 2, RH reported fourth-quarter financial results and missed its adjusted EPS and revenue estimates.</li>
</ul>
Analyst: Paul Newsome
<ul>
<li>Analyst Firm: Piper Sandler</li>
<li>Ratings Accuracy: 84%</li>
<li>Latest Rating: Maintained an Overweight rating on The Hanover Insurance Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THG#NYSE">THG</a>) and increased the price target from $190 to $205 on April 1. This analyst sees around 35% upside in the stock.</li>
<li>Recent News: On April 3, The Hanover appointed Richard W. Lavey as Chief Operating Officer.</li>
</ul>
Analyst: Josh Sullivan
<ul>
<li>Analyst Firm: Benchmark</li>
<li>Ratings Accuracy: 83%</li>
<li>Latest Rating: Maintained a Buy rating on TAT Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TATT#NASDAQ">TATT</a>) and increased the price target from $30 to $35 on April 3. This analyst sees around 37% upside in the stock.</li>
<li>Recent News: On March 26, TAT Technologies reported a year-over-year increase in fourth-quarter financial results.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44665280/how-to-earn-500-a-month-from-walgreens-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Walgreens Stock Ahead Of Q2 Earnings</a> </li>
</ul>
Photo via Shutterstock

TATT

5 Stock Picks Last Week From Wall Street's Most Accurate Analysts

Truist Securities analyst Mark Hughes maintains WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) with a Buy and raises the price target from $68 to $80.

Truist Securities Maintains Buy on WR Berkley, Raises Price Target to $80

BofA Securities analyst Joshua Shanker downgraded W.R. Berkley Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) from Buy to Neutral,<a target="_blank" href="https://www.benzinga.com/quote/WRB/analyst-ratings" rel="noreferrer noopener"> raising the price forecast to $74 from $73.</a>
The analyst suggests that Mitsui-Sumitomo&#8217;s plan to acquire a 15% stake in W.R. Berkley may not lead to a takeover soon, though it could be a long-term option.
The analyst mentions that W.R. Berkley is currently trading at 3.0 times its estimated book value for March 31, which is close to the highest point it&#8217;s ever reached, matching levels seen in April 2006 and November 2022. This trend of high price-to-book ratios is also observed in other large commercial property and casualty insurance companies, which are generally considered to be overvalued at the moment.
The high price-to-book ratio for W.R. Berkley is largely attributed to its strong return on equity, which is currently in the high teens, driving the elevated valuation despite the company not being as overvalued on a price-to-earnings basis.
Also Read:<a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/04/44591436/ionq-jumps-on-amazon-news-but-can-it-defy-quantum-bearish-trend" rel="noreferrer noopener"> IonQ Jumps On Amazon News, But Can It Defy Quantum Bearish Trend?</a>
Shanker suggests that Berkley benefits from lower exposure to casualty volatility compared to its peer stocks, and although some bearish investors are concerned about potential inadequacies in loss reserves (with short covering possibly explaining the recent stock surge), they believe Berkley is not facing greater challenges regarding loss trends than the industry as a whole.
Shanker states that, in general, they view commercial P&amp;C underwriters as overvalued.
The analyst notes that Berkley has better potential due to its higher return on equity, lower property risk, and the presence of a dedicated buyer in the market.
Despite this, Shanker sees limited upside for Berkley, which leads to a Neutral recommendation.
The analyst also mentions that some unique factors specific to Berkley&#8217;s stock prevent them from recommending an Underperform rating at the current stock price.
Price Action: WRB shares are trading lower by 1.41% to $70.16 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44588076/us-manufacturing-slips-into-contraction-as-tariff-driven-costs-hit-near-3-year-high" target="_blank" rel="noreferrer noopener">US Manufacturing Slips Into Contraction As Tariff-Driven Costs Hit Near 3-Year High</a></li>
</ul>
Image via Shutterstock.

Analyst Color

Equities

General

W.R. Berkley Nears Historical Price-To-Book High, Analyst Downgrades Stock On Overvaluation Concerns

In the preceding three months, 7 analysts have released ratings for WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for WR Berkley, presenting an average target of $62.43, a high estimate of $74.00, and a low estimate of $50.00. The average price target has stayed the same, reflecting a consistent view from analysts. 
<img src="https://www.benzinga.com/files/images/story/2025/1743512466_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A clear picture of WR Berkley's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$74.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$63.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$70.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$61.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$52.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$67.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$50.00</td>
<td>$56.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to WR Berkley. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of WR Berkley compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for WR Berkley's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
To gain a panoramic view of WR Berkley's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WRB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on WR Berkley analyst ratings.</a>
<h2>All You Need to Know About WR Berkley</h2>
W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.
<h3>WR Berkley's Economic Impact: An Analysis</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: WR Berkley's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 16.73%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: WR Berkley's net margin excels beyond industry benchmarks, reaching 15.48%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): WR Berkley's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 6.85%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.42%, the company showcases effective utilization of assets.
Debt Management: WR Berkley's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.34, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: WR Berkley Through The Eyes Of 7 Analysts

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Goldman Sachs analyst Kate McShane downgraded the rating for Genuine Parts Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) from Neutral to Sell and slashed the price target from $133 to $114. Genuine Parts shares closed at $119.14 on Monday. <a href="https://www.benzinga.com/quote/GPC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Sheila Kahyaoglu downgraded American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) from Buy to Hold and lowered the price target from $20 to $12. American Airlines shares closed at $10.55 on Monday. <a href="https://www.benzinga.com/quote/AAL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities analyst Joshua Shanker downgraded W. R. Berkley Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) from Buy to Neutral and raised the price target from $73 to $74. WR Berkley shares closed at $71.16 on Monday. <a href="https://www.benzinga.com/quote/WRB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Sheila Kahyaoglu downgraded Delta Air Lines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) from Buy to Hold and lowered the price target from $85 to $46. Delta Air Lines shares closed at $43.60 on Monday. <a href="https://www.benzinga.com/quote/DAL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities analyst Ken Hoexter downgraded Knight-Swift Transportation Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) from Buy to Neutral and lowered the price target from $66 to $46. Knight-Swift shares closed at $43.49 on Monday.  <a href="https://www.benzinga.com/quote/KNX/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying AAL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="632" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01083403/image-11-1024x632.png" alt="" class="wp-image-851099" style="width:560px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01083403/image-11-1024x632.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01083403/image-11-300x185.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01083403/image-11-768x474.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01083403/image-11.png 1082w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44561974/how-to-earn-500-a-month-from-apple-stock">How To Earn $500 A Month From Apple Stock</a></li>
</ul>
Photo via Shutterstock

This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

B of A Securities analyst Joshua Shanker downgrades WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) from Buy to Neutral and raises the price target from $73 to $74.

B of A Securities Downgrades WR Berkley to Neutral, Raises Price Target to $74

U.S. stocks were lower, with the Dow Jones index falling around 200 points on Friday.
Shares of Argan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) rose sharply during Friday's session following a fourth-quarter EPS and <a href="https://www.benzinga.com/quote/AGX/earnings">revenue beat</a>.
Argan reported quarterly earnings of $2.22 per share which beat the analyst consensus estimate of $1.15 per share. The company reported quarterly sales of $232.474 million which beat the analyst consensus estimate of $197.500 million.
Argan shares jumped 29.6% to $149.39 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>KULR Technology Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NYSE">KULR</a>) gained 16.7% to $1.7050 after the company reported better-than-expected quarterly sales results.</li>
<li>Abacus Global Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABL#NYSE">ABL</a>) rose 15.8% to $8.28 following strong quarterly sales.</li>
<li>TMC the metals company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) shares surged 14.7% to $1.95 following strong quarterly earnings</li>
<li>W. R. Berkley Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) gained 14.2% to $75.70 after Mitsui Sumitomo Insurance announced that it is planning to acquire a 15% stake in the company.</li>
<li>Braze, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) shares rose 13% to $41.54 as the company posted better-than-expected fourth-quarter results after Thursday's closing bell.</li>
<li>CureVac N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVAC#NASDAQ">CVAC</a>) gained 10.7% to $3.10 after the company announced it received a positive validity decision from the European Patent Office in its litigation against BioNTech SE.</li>
<li>Ascentage Pharma Group Internat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPG#NASDAQ">AAPG</a>) gained 9.3% to $22.07.</li>
<li>Zai Lab Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZLAB#NASDAQ">ZLAB</a>) rose 9.3% to $39.73.</li>
<li>Aeva Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NASDAQ">AEVA</a>) rose 8% to $6.89.</li>
<li>Harmony Gold Mining Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMY#NYSE">HMY</a>) climbed 7.8% to $13.85.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/25/03/44534992/how-to-earn-500-a-month-from-pvh-stock-ahead-of-q4-earnings"> </a>
<ul>
<li><a href="https://www.benzinga.com/25/03/44534992/how-to-earn-500-a-month-from-pvh-stock-ahead-of-q4-earnings">How To Earn $500 A Month From PVH Stock Ahead Of Q4 Earnings</a></li>
</ul>
Photo: Shutterstock

Intraday Update

Movers

AAPG

AEVA

BRZE

CVAC

KULR

ZLAB

Argan Posts Upbeat Results, Joins KULR Technology, Abacus Global Management, W. R. Berkley And Other Big Stocks Moving Higher On Friday

Press Releases

W. R. Berkley Corporation Establishes Branch Office of Berkley Insurance Company in India

W. R. Berkley Corporation to Announce Fourth Quarter and Full Year 2024 Earnings on January 27, 2025

W. R. Berkley Corporation Reports Fourth Quarter and Full Year 2024 Results

W. R. Berkley Corporation Declares Regular Quarterly Cash Dividend

W. R. Berkley Corporation Announces the Formation of Berkley Embedded Solutions

W. R. Berkley Corporation Appoints Heath Kidd as Executive Vice President

W. R. Berkley Corporation to Announce First Quarter 2025 Earnings on April 21, 2025

W. R. Berkley Corporation Confirms Mitsui Sumitomo Insurance Co. Intends to Purchase 15% of the Company's Shares in Open Market or Private Transactions From Third Parties

Comments

WR Berkley

Noticias

Últimas noticias sobre WR Berkley (NYSE:WRB) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL